Novel strategies targeting residual risk: The promise of PCSK9 inhibiting therapies
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Martin Cowie, MD
- ESC 2016Mendelian randomisation study suggests that CV prevention could be simpler and more effective
Dr. Brian Ference
Peter van der Meer, MD
Seth Shay Martin, MD